Press Releases

News from the year: /2013

Notice of Interim Results

London, UK – 1 September 2021: Oxford Biomedica plc (LSE:OXB), a leading gene and cell therapy group, will be announcing its interim results for the six months ended 30 June…

Read more

Board Changes

Oxford, UK – 3 February, 2021: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading gene and cell therapy group, today announces two changes to the Group’s Board…

Read more